Endocrine News and Research

RSS

Facelift incision with no-neck-scar approach safe and effective for thyroid patients

A facelift incision and robotics can help surgeons safely remove a portion of a diseased thyroid from some patients without the characteristic neck scar.

1 Jun 2011

Sleep loss reduces healthy young man's testosterone levels

Cutting back on sleep drastically reduces a healthy young man's testosterone levels, according to a study published in the June 1 issue of the Journal of the American Medical Association.

1 Jun 2011

Tigris Pharmaceuticals begins enrollment in AFP-464 Phase 2 trial in ER-positive breast cancer

Tigris Pharmaceuticals, Inc., today announced enrollment of its first patient in a randomized Phase 2 clinical trial of AFP-464 with or without Faslodex in estrogen receptor (ER)-positive breast cancer patients.

27 May 2011

Study examines effects of psychotherapy on cortisol stress hormone

In a study published in the current issue of Psychotherapy and Psychosomatics the effects of psychotherapy on cortisol, the most important stress hormone, are examined.

25 May 2011

Aeterna Zentaris first quarter revenues increase to $7.4 million

Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today reported financial and operating results as at and for the first quarter ended March 31, 2011.

18 May 2011

High IGF-I hormone levels linked with better long-term recovery after stroke

Insulin-like growth factor I, IGF-I, is a hormone that is found in the blood and contributes to, among other things, growth and bone mass. The levels of this hormone are higher in people who exercise regularly and those with good health. Scientists at the Sahlgrenska Academy have shown for the first time that high levels of this hormone are associated with better long-term recovery after a stroke.

17 May 2011

GATTEX Phase 3 study results in adult short bowel syndrome presented at DDW 2011

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced that GATTEX, a novel, recombinant analog of human glucagon-like peptide 2, was found to effectively and safely reduce parenteral support volume in adult short bowel syndrome-intestinal failure patients.

11 May 2011

Women with invasive breast cancer can benefit from new genomic test

A new genomic test combining multiple signatures - a patient's estrogen receptor status, endocrine therapy response, chemotherapy resistance and sensitivity - shows promise as a predictor of chemotherapy response and survival benefit in women with invasive breast cancer, according to research led by The University of Texas MD Anderson Cancer Center.

11 May 2011

Abbott receives CE Mark approval for new blood glucose monitoring system

Abbott today announced that it has received CE Mark for its new FreeStyle InsuLinx Blood Glucose Monitoring System, the first blood glucose monitoring device from Abbott that includes a mealtime insulin calculator for calculating suggested insulin doses.

10 May 2011

Maternal exposure to BPA during pregnancy linked to decrease in birth weight of children

Parental exposure to bisphenol A (BPA) during pregnancy is associated with decreased birth weight of offspring, compared with offspring from families without parental BPA exposure in the workplace, according to Kaiser Permanente researchers.

6 May 2011

Researchers identify unexpected triple-negative breast cancer marker

German researchers have identified an unexpected molecular marker that predicts how sensitive hard-to-treat triple-negative breast cancers are to chemotherapy.

5 May 2011

OU-COM receives Osteopathic Heritage Foundation grant to address healthcare issues

The Osteopathic Heritage Foundations' $105 million award to Ohio University's College of Osteopathic Medicine represents the largest private donation ever given to a college or university in Ohio. This gift will be used to address some of the most pressing health care issues across the state and the nation - the impending shortage of primary care physicians and the diabetes epidemic.

2 May 2011

UCLA study findings hold promise to cure diabetes

Simply put, people develop diabetes because they don't have enough pancreatic beta cells to produce the insulin necessary to regulate their blood sugar levels.

30 Apr 2011

LSI announces publication of Emerging Medtech Companies report

Life Science Intelligence, a leading medical technology market intelligence firm, has announced the publication of its Report on Emerging Medtech Companies in Q1 2011.

30 Apr 2011

FDA approves Abbott's AndroGel for hypogonadism treatment in men

Abbott announced today that the U.S. Food and Drug Administration has approved AndroGel 1.62%, a clear, odorless, gel formulation shown to restore testosterone levels in hypogonadal men with half the volume of gel at the starting dose compared to AndroGel 1%.

30 Apr 2011

Antibiotics may serve as effective treatment for appendicitis than surgery

Antibiotics rather than surgery may be the better treatment for cases of appendicitis in which the appendix hasn't burst, according to a new study.

29 Apr 2011

Study examines racial differences between obesity and vitamin D among children

A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism found that while black and white children with vitamin D deficiency both had higher fat levels, black children were more likely to have higher levels of fat just under their skin and white children were more likely to have higher levels of fat between their internal organs.

28 Apr 2011

High metabolic rates linked to accelerated aging in humans

A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism found that higher metabolic rates predict early natural mortality, indicating that higher energy turnover may accelerate aging in humans.

27 Apr 2011

Nationwide researchers to launch Oncotype DX test phase III trial in breast cancer

Cancer researchers at hundreds of sites nationwide are about to launch a SWOG-led clinical trial that could keep thousands of breast cancer patients from getting chemotherapy that is unlikely to do them any good.

27 Apr 2011

Abuse during childhood substantially increases risk of depression in adolescence

Queen's University professor Kate Harkness has found that a history of physical, sexual or emotional abuse in childhood substantially increases the risk of depression in adolescence by altering a person's neuroendocrine response to stress.

21 Apr 2011